NL9301877A - 1-Beta-methyl-2-thiol-carbapenem-derivaten. - Google Patents

1-Beta-methyl-2-thiol-carbapenem-derivaten. Download PDF

Info

Publication number
NL9301877A
NL9301877A NL9301877A NL9301877A NL9301877A NL 9301877 A NL9301877 A NL 9301877A NL 9301877 A NL9301877 A NL 9301877A NL 9301877 A NL9301877 A NL 9301877A NL 9301877 A NL9301877 A NL 9301877A
Authority
NL
Netherlands
Prior art keywords
formula
methyl
amino
thiol
carbapenem
Prior art date
Application number
NL9301877A
Other languages
English (en)
Dutch (nl)
Original Assignee
Dong Kook Pharmaceutical Co
Ki Beom Kwon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dong Kook Pharmaceutical Co, Ki Beom Kwon filed Critical Dong Kook Pharmaceutical Co
Publication of NL9301877A publication Critical patent/NL9301877A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NL9301877A 1993-06-15 1993-11-01 1-Beta-methyl-2-thiol-carbapenem-derivaten. NL9301877A (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR930010878 1993-06-15
KR930010878 1993-06-15
US15547793 1993-11-19
US08/155,477 US5463046A (en) 1993-06-15 1993-11-19 1-β-methyl-2-thiolic carbapenem derivatives

Publications (1)

Publication Number Publication Date
NL9301877A true NL9301877A (nl) 1995-01-02

Family

ID=26629717

Family Applications (1)

Application Number Title Priority Date Filing Date
NL9301877A NL9301877A (nl) 1993-06-15 1993-11-01 1-Beta-methyl-2-thiol-carbapenem-derivaten.

Country Status (13)

Country Link
US (1) US5463046A (fr)
JP (1) JP2531489B2 (fr)
KR (1) KR950000700A (fr)
CN (1) CN1100100A (fr)
AU (1) AU4912393A (fr)
BR (1) BR9400695A (fr)
CA (1) CA2102003A1 (fr)
DE (1) DE4335984A1 (fr)
ES (1) ES2070790B1 (fr)
FR (1) FR2706460A1 (fr)
GB (1) GB2279073A (fr)
IT (1) IT1270183B (fr)
NL (1) NL9301877A (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2099817A1 (fr) * 1992-07-21 1994-01-22 Frederic H. Jung Composes antibiotiques
NZ324447A (en) * 1995-12-21 1999-08-30 Sankyo Co 1-methyl-carbapenem substituted by a 4-pyrrolidinylthio group and medicaments
KR100309703B1 (ko) * 1999-01-18 2001-10-29 박호군 이중고리 티올 유도체, 이를 치환기로 갖는 1-β-메틸-카바페넴 유도체, 및 그들의 제조방법
CN101260108B (zh) * 2007-03-11 2010-06-02 山东轩竹医药科技有限公司 巯基吡咯烷酮碳青霉烯类衍生物
US10695322B2 (en) 2016-01-29 2020-06-30 The Johns Hopkins University Inhibitors of bacterial growth

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1283906C (fr) * 1983-05-09 1991-05-07 Makoto Sunagawa COMPOSE DE .beta.-LACTAM ET PROCEDE DE PRODUCTION
JPS60233076A (ja) * 1984-05-03 1985-11-19 Sumitomo Chem Co Ltd 新規なβ−ラクタム化合物およびその製造法
ES2051700T3 (es) * 1986-03-27 1994-07-01 Sumitomo Pharma Un proceso para la preparacion de un compuesto beta-lactama.
DE3784147T2 (de) * 1986-11-24 1993-06-03 Fujisawa Pharmaceutical Co 3-pyrrolidinylthio-1-azabicyclo(3.2.0)hept-2-en-2-carbonsaeure-derivate.
NO168304C (no) * 1988-04-01 1992-02-05 Sankyo Co Analogifremgangsmaate til fremstilling av terapeutisk aktive 2-(heterocyklyltio)karbapenemderivater
CA2022382A1 (fr) * 1989-08-02 1991-02-03 Susumu Nakagawa Derives de piperidylthiocarbapenem
CA2036163C (fr) * 1990-02-14 2001-06-19 Makoto Sunagawa Nouveaux composes de beta-lactame et leur production
US5227376A (en) * 1990-02-14 1993-07-13 Sumitomo Pharmaceuticals Co., Ltd. β-lactam compounds and their production
IE910606A1 (en) * 1990-02-23 1991-08-28 Sankyo Co Carbapenem derivatives having antibiotic activity, their¹preparation and their use
AU644008B2 (en) * 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use
GB9107341D0 (en) * 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds
JP2559949B2 (ja) * 1991-06-04 1996-12-04 三共株式会社 1−メチルカルバペネム誘導体

Also Published As

Publication number Publication date
JP2531489B2 (ja) 1996-09-04
ES2070790A1 (es) 1995-06-01
CN1100100A (zh) 1995-03-15
ITMI941191A0 (it) 1994-06-08
ES2070790B1 (es) 1996-03-16
GB2279073A (en) 1994-12-21
IT1270183B (it) 1997-04-29
JPH06345766A (ja) 1994-12-20
DE4335984A1 (de) 1994-12-22
KR950000700A (ko) 1995-01-03
US5463046A (en) 1995-10-31
ITMI941191A1 (it) 1995-12-08
BR9400695A (pt) 1995-01-10
AU4912393A (en) 1994-12-22
CA2102003A1 (fr) 1994-12-16
GB9411844D0 (en) 1994-08-03
FR2706460A1 (fr) 1994-12-23

Similar Documents

Publication Publication Date Title
EP0160391B1 (fr) Dérivés de carbapénème et compositions les contenant
EP0924210B1 (fr) Dérivés de 2-(1-(1,3-thiazolin-2-yl)azétidin-3-yl)thio-carbapénème
US4536335A (en) Carbapenem antibiotics
HU201762B (en) Process for producing 3-pyrrolidinylthio-1-azobicyclo(3.2.0)hept-2-en-2-carboxylic acid derivatives
NL9301877A (nl) 1-Beta-methyl-2-thiol-carbapenem-derivaten.
CA1254562A (fr) Composes de carbapenem, preparation et utilisation
EP0560613B1 (fr) Dérivés antimicrobiens du carbapenem, leur préparation et leur utilisation thérapeutique
GB2159818A (en) Carbapenem intermediates
EP1340756B1 (fr) Nouveaux composes de beta-lactame et leur procede de production
US4771046A (en) Carbapenem derivatives
CS247168B2 (en) Method of new carbapenem derivatives production
IE910978A1 (en) 2-(substituted pyrrolidinylthio)carbapenem derivatives
GB2124625A (en) Fluoralkylated carbapenem derivatives
JP3199300B2 (ja) 1−メチルカルバペネム誘導体
US4820815A (en) Azetidinone N-phosphonomethyl esters
SE460197B (sv) Nya karbapenemderivat och foerfarande foer framstaellning daerav
Lee et al. Studies on the synthesis and structure-activity relationships of 2-(2-functionalized pyrrolidin-4-ylthio)-1β-methylcarbapenems
CS259892B2 (en) Method of 6-(1-hydroxyethyl)-7-oxo-1-azabiclo/3,2,o/hept-en-2-carboxyl acid's derivatives production
CH686516A5 (de) 1-Beta-Methyl-2-thiolin-carbapenem-derivate.

Legal Events

Date Code Title Description
A1B A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed